Extracellular Vesicles as Biomarkers for Acute Respiratory Distress Syndrome
School Name
Academic Magnet High School
Grade Level
10th Grade
Presentation Topic
Physiology and Health
Presentation Type
Mentored
Abstract
Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. Acute respiratory distress syndrome (ARDS) is a secondary disease that may follow sepsis and is characterized by inflammation, increased vascular ermeability, and endothelial cell dysfunction. Currently, there are no approved pharmacological treatments. Extracellular vesicles (EVs) are membranous microvesicles secreted from the endosomal compartment or plasma membrane of cells. Recent evidence suggests that circulating EVs from septic patients are associated with inflammation and vascular permeability, so we investigated circulating EVs as potential biomarkers for sepsis-induced ARDS. To do this, we collected plasma samples from 85 ICU-administered septic patients, 21 of whom developed ARDS, as well as healthy controls. EVs were extracted from these samples and subsequently added to HMVECs. Transendothelial electrical resistance (TEER) assays were performed on the HMVECs, and the resulting data was used as an indication of vascular permeability. We found that EVs from ARDS patients (n=21) have a higher chance (81% vs 37.5%) to induce TEER compared to non-ARDS patients (n=64). These findings may eventually lead to a screening strategy to determine a patient's risk of ARDS development based on their EVs. We also wanted to explore potential explanations for this phenomenon. Previous studies suggest that EVs containing caspase-1 induce endothelial cell injury, so we determined caspase-1 activity in the EVs and discovered that EVs from septic patients contain significantly higher caspase-1 activity than healthy controls, and EVs from ARDS patients have higher caspase-1 activity than EVs from septic patients without ARDS.
Recommended Citation
Fan, Kevin, "Extracellular Vesicles as Biomarkers for Acute Respiratory Distress Syndrome" (2020). South Carolina Junior Academy of Science. 165.
https://scholarexchange.furman.edu/scjas/2020/all/165
Location
Furman Hall 201
Start Date
3-28-2020 10:14 AM
Presentation Format
Oral and Written
Group Project
No
Extracellular Vesicles as Biomarkers for Acute Respiratory Distress Syndrome
Furman Hall 201
Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. Acute respiratory distress syndrome (ARDS) is a secondary disease that may follow sepsis and is characterized by inflammation, increased vascular ermeability, and endothelial cell dysfunction. Currently, there are no approved pharmacological treatments. Extracellular vesicles (EVs) are membranous microvesicles secreted from the endosomal compartment or plasma membrane of cells. Recent evidence suggests that circulating EVs from septic patients are associated with inflammation and vascular permeability, so we investigated circulating EVs as potential biomarkers for sepsis-induced ARDS. To do this, we collected plasma samples from 85 ICU-administered septic patients, 21 of whom developed ARDS, as well as healthy controls. EVs were extracted from these samples and subsequently added to HMVECs. Transendothelial electrical resistance (TEER) assays were performed on the HMVECs, and the resulting data was used as an indication of vascular permeability. We found that EVs from ARDS patients (n=21) have a higher chance (81% vs 37.5%) to induce TEER compared to non-ARDS patients (n=64). These findings may eventually lead to a screening strategy to determine a patient's risk of ARDS development based on their EVs. We also wanted to explore potential explanations for this phenomenon. Previous studies suggest that EVs containing caspase-1 induce endothelial cell injury, so we determined caspase-1 activity in the EVs and discovered that EVs from septic patients contain significantly higher caspase-1 activity than healthy controls, and EVs from ARDS patients have higher caspase-1 activity than EVs from septic patients without ARDS.